Patients’ characteristics

Patient ID	Age/Sex	Stage	Meta site	MSKCC	Histology	Grade	Prior treatment
1802	72/F	pT3aN2M1	Lung, LN	Poor	Clear cell	2 > 3	Sunitinib
1803	72/M	pT3bN0M1	Liver, lung, bone	Poor	Clear cell	3 > 2	IFN-α, radiation
1806	72/F	pT4N1M1	Lung, LN	Intermediate	Clear cell	3	no
1808	75/M	pT3aN2M1	Lung, LN, bone	Intermediate	Unclassified	3	no
1812	61/M	pT1bN1M1	LN	Intermediate	Clear cell	2 > 1> > 3	no
1814	55/M	pT3aN0M1	Lung	Intermediate	Clear cell	2	no
1817	64/F	pT3bN1M1	Lung, LN, bone	Intermediate	Clear cell	3 > 2	no
1823	57/M	pT1N0M1	Lung, pleura	Intermediate	Clear cell	2 > 3	no

MSKCC, Memorial Sloan Kettering Cancer Center risk criteria; LN, lymph node.